• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

硝酸4-(6-氟-1,2-苯并异恶唑-3-基)-1-[2-(2-甲基-4-氧代-6,7,8,9-四氢-4H-吡啶并[1,2-a]嘧啶-3-基)乙基]哌啶鎓

4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-[2-(2-methyl-4-oxo-6,7,8,9-tetra-hydro-4H-pyrido[1,2-a]pyrimidin-3-yl)eth-yl]piperidinium nitrate.

作者信息

Sun Yu, Zhang Huai-Hong

出版信息

Acta Crystallogr Sect E Struct Rep Online. 2009 Jun 20;65(Pt 7):o1647. doi: 10.1107/S1600536809022016.

DOI:10.1107/S1600536809022016
PMID:21582911
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2969342/
Abstract

In the risperidone cation of the title compound, C(23)H(28)FN(4)O(2) (+)·NO(3) (-), the piperidine ring adopts a chair conformation and the tetra-hydro-pyridine ring is disordered over two orientations in a 0.620 (11):0.380 (11) ratio. N-H⋯O, C-H⋯O and C-H⋯F hydrogen bonds are present in the crystal structure.

摘要

在标题化合物C(23)H(28)FN(4)O(2) (+)·NO(3) (-)的利培酮阳离子中，哌啶环呈椅式构象，四氢吡啶环在两种取向上无序，比例为0.620 (11):0.380 (11)。晶体结构中存在N-H⋯O、C-H⋯O和C-H⋯F氢键。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e545/2969342/adad881a94cf/e-65-o1647-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e545/2969342/b0c681d52d53/e-65-o1647-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e545/2969342/adad881a94cf/e-65-o1647-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e545/2969342/b0c681d52d53/e-65-o1647-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e545/2969342/adad881a94cf/e-65-o1647-fig2.jpg

相似文献

1
4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-[2-(2-methyl-4-oxo-6,7,8,9-tetra-hydro-4H-pyrido[1,2-a]pyrimidin-3-yl)eth-yl]piperidinium nitrate.硝酸4-(6-氟-1,2-苯并异恶唑-3-基)-1-[2-(2-甲基-4-氧代-6,7,8,9-四氢-4H-吡啶并[1,2-a]嘧啶-3-基)乙基]哌啶鎓
Acta Crystallogr Sect E Struct Rep Online. 2009 Jun 20;65(Pt 7):o1647. doi: 10.1107/S1600536809022016.
2
Paliperidonium nitrate.硝酸帕利哌酮
Acta Crystallogr Sect E Struct Rep Online. 2012 Oct 1;68(Pt 10):o2932. doi: 10.1107/S160053681203841X. Epub 2012 Sep 15.
3
Paliperidone: 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]eth-yl}-9-hy-droxy-2-methyl-1,6,7,8,9,9a-hexa-hydro-pyrido[1,2-a]pyrimidin-4-one.帕利哌酮：3-{2-[4-(6-氟-1,2-苯并恶唑-3-基)哌啶-1-基]乙基}-9-羟基-2-甲基-1,6,7,8,9,9a-六氢吡啶并[1,2-a]嘧啶-4-酮。
Acta Crystallogr Sect E Struct Rep Online. 2011 Nov;67(Pt 11):o2945-6. doi: 10.1107/S160053681104164X. Epub 2011 Oct 12.
4
2-(Dibutyl-amino)-3-(4-fluoro-phen-yl)-5,6,7,8-tetra-hydro-7-methyl-6,8-di-phenyl-pyridine-[3',4':2,3]thieno[5,4-d]pyrimidin-4(3H)-one.2-（二丁基氨基）-3-（4-氟苯基）-5,6,7,8-四氢-7-甲基-6,8-二苯基吡啶-[3',4':2,3]噻吩并[5,4-d]嘧啶-4（3H）-酮
Acta Crystallogr Sect E Struct Rep Online. 2008 Jan 30;64(Pt 2):o535. doi: 10.1107/S1600536808002845.
5
1-[4-(4-Fluoro-phen-yl)-6-methyl-2-sulfanyl-idene-1,2,3,4-tetra-hydro-pyrimidin-5-yl]ethanone.1-[4-(4-氟苯基)-6-甲基-2-硫亚基-1,2,3,4-四氢嘧啶-5-基]乙酮
Acta Crystallogr Sect E Struct Rep Online. 2012 Sep 1;68(Pt 9):o2625. doi: 10.1107/S1600536812033727. Epub 2012 Aug 1.
6
2-Amino-5-methyl-3-(2-oxo-2-phenyl-eth-yl)-7-phenyl-4,5,6,7-tetra-hydro-3H-[1,2,4]triazolo[1,5-a]pyrimidin-8-ium bromide ethanol monosolvate.2-氨基-5-甲基-3-(2-氧代-2-苯基乙基)-7-苯基-4,5,6,7-四氢-3H-[1,2,4]三唑并[1,5-a]嘧啶-8-鎓溴化物乙醇单溶剂合物
Acta Crystallogr Sect E Struct Rep Online. 2013 Sep 25;69(Pt 10):o1586-7. doi: 10.1107/S1600536813025853. eCollection 2013.
7
3-Ethyl 5-methyl 2-hydr-oxy-6-methyl-4-(4-nitro-phen-yl)-2-trifluoro-methyl-1,2,3,4-tetra-hydro-pyridine-3,5-dicarboxyl-ate.3-乙基 5-甲基 2-羟基-6-甲基-4-(4-硝基苯基)-2-三氟甲基-1,2,3,4-四氢吡啶-3,5-二羧酸酯
Acta Crystallogr Sect E Struct Rep Online. 2008 Aug 9;64(Pt 9):o1737. doi: 10.1107/S1600536808024835.
8
Ethyl 4-(2-bromo-5-fluoro-phen-yl)-6-methyl-1-phenyl-2-thioxo-1,2,3,4-tetra-hydro-pyrimidine-5-carboxyl-ate.4-(2-溴-5-氟苯基)-6-甲基-1-苯基-2-硫代-1,2,3,4-四氢嘧啶-5-羧酸乙酯
Acta Crystallogr Sect E Struct Rep Online. 2008 Jul 19;64(Pt 8):o1526-7. doi: 10.1107/S1600536808021685.
9
Ethyl 4-[3,5-bis-(trifluoro-meth-yl)phen-yl]-6-methyl-2-oxo-1,2,3,4-tetra-hydro-pyrimidine-5-carboxyl-ate.4-[3,5-双-(三氟甲基)苯基]-6-甲基-2-氧代-1,2,3,4-四氢嘧啶-5-羧酸乙酯
Acta Crystallogr Sect E Struct Rep Online. 2009 May 29;65(Pt 6):o1404-5. doi: 10.1107/S1600536809019035.
10
(4-Fluoro-phen-yl)[6-(2-fur-yl)-7-nitro-2,3,4,6,7,8-hexa-hydro-1H-pyrido[1,2-a]pyrimidin-9-yl]methanone.（4-氟苯基）[6-（2-呋喃基）-7-硝基-2,3,4,6,7,8-六氢-1H-吡啶并[1,2-a]嘧啶-9-基]甲酮
Acta Crystallogr Sect E Struct Rep Online. 2009 Jul 15;65(Pt 8):o1869. doi: 10.1107/S1600536809026373.

引用本文的文献

1
Paliperidone: 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]eth-yl}-9-hy-droxy-2-methyl-1,6,7,8,9,9a-hexa-hydro-pyrido[1,2-a]pyrimidin-4-one.帕利哌酮：3-{2-[4-(6-氟-1,2-苯并恶唑-3-基)哌啶-1-基]乙基}-9-羟基-2-甲基-1,6,7,8,9,9a-六氢吡啶并[1,2-a]嘧啶-4-酮。
Acta Crystallogr Sect E Struct Rep Online. 2011 Nov;67(Pt 11):o2945-6. doi: 10.1107/S160053681104164X. Epub 2011 Oct 12.
2
3-{[5-(4-Bromo-phen-yl)imidazo[2,1-b][1,3,4]thia-diazol-2-yl]meth-yl}-1,2-benzoxazole.3-{[5-(4-溴苯基)咪唑并[2,1-b][1,3,4]噻二唑-2-基]甲基}-1,2-苯并恶唑
Acta Crystallogr Sect E Struct Rep Online. 2010 Dec 18;67(Pt 1):o154. doi: 10.1107/S1600536810052232.
3

本文引用的文献

1
A short history of SHELX.SHELX简史。
Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22. doi: 10.1107/S0108767307043930. Epub 2007 Dec 21.
2
Safety and tolerability: how do newer generation "atypical" antipsychotics compare?安全性与耐受性：新一代“非典型”抗精神病药物如何比较？
Psychiatr Q. 2002 Winter;73(4):297-311. doi: 10.1023/a:1020464017021.
3
Olanzapine. Pharmacokinetic and pharmacodynamic profile.奥氮平。药代动力学和药效学概况。
3-{[6-(4-Chloro-phen-yl)imidazo[2,1-b][1,3,4]thia-diazol-2-yl]meth-yl}-1,2-benzoxazole.
3-{[6-(4-氯苯基)咪唑并[2,1-b][1,3,4]噻二唑-2-基]甲基}-1,2-苯并恶唑
Acta Crystallogr Sect E Struct Rep Online. 2011 Feb 12;67(Pt 3):o617-8. doi: 10.1107/S1600536811004582.
Clin Pharmacokinet. 1999 Sep;37(3):177-93. doi: 10.2165/00003088-199937030-00001.